✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹3,558 Cr.
P/E
18.35
About
India Glycols Limited is a public company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. The company manufactures Industrial Chemicals such as gr… Read more
India Glycols Limited is a public company domiciled in India and is incorporated under the pro… Read more
Low
679
52W Range
High
1549
  • India Glycols
  • Foseco India
  • NOCIL
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Capex

Asset Break-Up

Operational Metrics

    Select a Metric
    • Realization/Tonne - Ethylene Oxide Derivatives (Rs/MT)
    • Realization/Tonne - Glycol (Rs/MT)
    Peer Comparison
    Suppliers
    • Time Technoplast Ltd.
    FAQs on India Glycols Ltd. Business

    India Glycols Limited, a public company based in India, specializes in manufacturing Industrial Chemicals like green technology based bulk, specialty and performance chemicals, natural gums, industrial gases, Ethyl Alcohol, and nutraceuticals.

    India Glycols major competitors are NOCIL, Foseco India, Grauer & Weil (I), Yasho Industries, Neogen Chemicals, GHCL, IG Petrochem..
    Market Cap of India Glycols is ₹3,605 Crs.
    While the median market cap of its peers are ₹4,607 Crs.

    India Glycols seems to be less financially stable compared to its competitors.
    Altman Z score of India Glycols is 1.77 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis